The speed, flexibility and strong risk-benefit ratio of virtual clinical trials could all be highlighted in the assessment of potential Covid-19 treatments, according to industry bosses. Dr Calvin H Knowlton, chairman and CEO of US healthtech firm TRHC (Tabula Rasa…
Why Asia-Pacific attracts 60% of all ongoing and planned hepatology trials globally
There are more than 1,300 clinical trials in hepatology, either ongoing or planned, in Asia-Pacific. This represents about 60% of all ongoing and planned hepatology trials globally. Liver diseases are highly prevalent in the Asia-Pacific region. The region hosts some…
First Covid-19 vaccine candidate trial begins in Australia
The first clinical trials of a Covid-19 vaccine developed in Australia have commenced at Royal Adelaide Hospital’s PARC Clinical Research facility. Named COVAX-19, the targeted vaccine has been developed by company Vaxine and researchers at Flinders University. During the first…
Sanofi and Regeneron’s Kevzara fails in Phase III Covid-19 trial
Sanofi and Regeneron Pharmaceuticals have reported that a Phase III clinical trial of rheumatoid arthritis drug Kevzara (sarilumab) failed to meet its primary and key secondary endpoints in Covid-19 patients who required mechanical ventilation in the US. The study compared…
Abivax doses first patient in Phase II/III Covid-19 clinical trial
French biotechnology company Abivax has dosed the first patient in its Phase II/III study of ABX464 in Covid-19 patients at the University Hospital Center in Nice, France. This randomised, double-blind, placebo-controlled miR-AGE study investigates the effect of early treatment in…
Durham-based IQVIA to launch massive clinical research site in Canada
RESEARCH TRIANGLE PARK — IQVIA has secured a deal with LMC Manna Research to launch what it says is the largest clinical research site in Canada. That adds to its network of more than 980 Prime and Partner clinical sites…
13 COVID-19 Vaccines Are in Human Clinical Trials – What Are They?
The world is now several months into the COVID-19 global pandemic caused by the SARS-CoV-2 virus. As lockdown restrictions slowly begin to lift in certain regions, the pursuit for a safe and effective vaccine against the virus continues – and…
